The Cigna Group
Leadership History
2 leaders · 2009 to present
Brian Evanko is the CEO of Cigna, in the role since 2026. The first chief executive was David M. Cordani, from 2009.
| Name | Role | From | To | Years in role |
|---|---|---|---|---|
| Brian Evanko | President and Chief Executive Officer | 2026 | Present | < 1 |
| David M. Cordani | Executive Chair; former Chairman and CEO | 2009 | 2026 | 17 |
The Cigna Group is best understood as a pharmacy-services company attached to an employer health benefits business. Evernorth Health Services, built around the 2018 Express Scripts acquisition, generates most of the revenue, while Cigna Healthcare serves about 18.4 million medical customers in the U.S. and abroad (June 30, 2026). The company counted about 182.8 million total customer relationships at mid-2026 and is based in Bloomfield, Connecticut.
Cigna makes money in two ways. Evernorth Health Services, the larger business by revenue, runs Express Scripts pharmacy benefit management, Accredo specialty pharmacy, home-delivery pharmacy, eviCore utilization management and MDLive virtual care; it earns dispensing margins, administrative and service fees, and purchasing economics on prescription drugs for health plans and employers. Cigna Healthcare sells employer and individual health coverage in the U.S. and internationally. Most of its U.S. medical customers are in self-funded (ASO) plans, where the employer pays claims and Cigna collects fees for networks, claims processing and care management, while insured plans earn premiums. In October 2025 Cigna announced a rebate-free Express Scripts model that shifts pharmacy economics toward upfront discounts and transparent fees.
President and Chief Executive Officer
2026 – Present
0 years (current)
Evanko joined Cigna in 1998 through its actuarial development program, served as CFO, led Cigna Healthcare and was named president and COO in March 2025 before becoming CEO on July 1, 2026. He holds an actuarial science degree from Penn State and the FSA and CFA designations.
Executive Chair; former Chairman and CEO
2009 – 2026
17 years
Cordani joined Cigna in 1991 after working at Coopers & Lybrand, became president of Cigna HealthCare in 2005 and CEO in December 2009. Over his 17 years as CEO he led the Express Scripts acquisition, the Evernorth launch, the 2023 rename to The Cigna Group and the 2025 Medicare exit. He became executive chair when Evanko took over in July 2026.
Cigna's biggest pressure point is PBM reform. The FTC sued the three largest PBMs over insulin pricing in 2024, and Express Scripts settled in February 2026 by agreeing to delink manufacturer compensation from list prices, expand transparency reporting and ensure members pay the lowest available price. Congress and many states continue to pursue PBM legislation, and the company's own move to a rebate-free model will change how Evernorth earns money. A second challenge is medical cost trend: specialty drugs, GLP-1 obesity medicines and higher utilization pressure Cigna Healthcare's medical care ratio and stop-loss products. Third, Evernorth relies on large client contracts, so renewals and the loss of major accounts can swing revenue. Finally, the stock has lagged: market capitalization was about $72 billion in late September 2026, well below 2024 levels, putting pressure on the new CEO to show durable earnings growth.
Brian Evanko became CEO of The Cigna Group on July 1, 2026, succeeding David Cordani, who had led the company since December 2009 and oversaw the $54 billion Express Scripts acquisition in 2018. Cordani became executive chair of the board.
David Cordani, an accountant and MBA graduate who worked at Coopers & Lybrand, joined Cigna in 1991, rising through senior leadership roles including Chief Financial Officer of Cigna HealthCare, President of Cigna HealthCare, and President and Chief Operating Officer of Cigna Corporation.
H. Edward Hanway served as CEO of Cigna from 2000 to 2009. Hanway restructured Cigna following the 1998 financial crisis, divested non-core life and property casualty operations, and focused the company exclusively on health and employee benefits.
Anthem agreed to acquire Cigna for about $54 billion in 2015. A federal court blocked the deal in 2017, and in 2020 Delaware's Court of Chancery ruled that neither company was owed damages or the $1.85 billion termination fee.
Cordani led the 2018 acquisition of Express Scripts, valued at about $67 billion including debt, which turned Cigna into a pharmacy-led health services company.
In September 2020, David Cordani launched Evernorth Health Services as a distinct brand umbrella uniting Express Scripts, Accredo, eviCore, and clinical health services, creating an open-architecture partner for health plans and employers.
David Cordani has served as CEO since 2009. He is heavily credited with executing the massive, company-altering $54 billion acquisition of Express Scripts, completely shifting Cigna away from just traditional insurance.
Compare executive leadership tenures and strategic transitions
Explore Cigna
Core profile pages, founders and related research hubs for this company.